Recombinant VZV ORF9 Protein (VAng-Lsx0549)
Recombinant VZV ORF9 protein containing the VZV ORF9 immunodominant regions, amino acids 6-28, 76-100 was expressed in E. coli and purified by proprietary chromatographic technique.
Datasheet
Specifications
Target
Varicella Zoster Virus
Type
Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
25mM Tris-Hcl pH 8.0, 1mM EDTA and 50 % glycerol.
Purity
> 95 % pure by 10 % SDS-PAGE.
Storage
Store at 4 °C short term, -20 °C long term.
Antigen Information
Introduction
Varicella zoster virus or varicella-zoster virus (VZV) belongs to the family of Herpesviridae. VZV also known as chickenpox virus, varicella virus, zoster virus, and human herpesvirus type 3 (HHV-3). It is one of the eight herpesviruses known to infect humans. VZV multiplies in the lungs and causes a wide variety of symptoms. It causes chickenpox (varicella), a disease most commonly affecting children, teens, and young adults, and herpes zoster (shingles) in older adults; shingles is rare in children. After many years of recovery from the chickenpox, VZV can be re-activated and performed as herpes zoster.
Alternative Names
VZV Ag, ORF9; Varicella-Zoster Virus ORF9; varicella-zoster virus; VZV; Herpesviridae; Varicellovirus; vzv; orf9; varicella zoster
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
